Insmed Incorporated (NASDAQ: $INSM) is a US biopharmaceutical company specializing in developing and commercializing novel therapeutics for serious and rare ailments. On Tuesday, May 28, […]
Category: Biotech
Rallybio (NASDAQ: $RLYB) Skyrockets 82%+ on Thursday After Announcing Johnson & Johnson Partnership
Rallybio (NASDAQ: $RLYB) is a clinical-stage biotech firm working on life-changing therapies for patients with severe and rare diseases. Headquartered in Connecticut, the company’s portfolio […]
Viking Therapeutics (NASDAQ: $VKTX) Surges 16+% on Tuesday on Promising Weigh Loss Pill Trial ResultsÂ
Viking Therapeutics (NASDAQ: $VKTX) is a clinical-stage biopharmaceutical company located in San Diego, CA, focused on pioneering therapies for metabolic and endocrine conditions. It targets […]
Fusion Pharma (NASDAQ: $FUSN) Soars 97% on AstraZeneca Buyout for $2.4B in CashÂ
Fusion Pharmaceuticals (NASDAQ: $FUSN), a Canadian biotech, has been acquired by British-Swedish Biotech giant AstraZeneca (NASDAQ: $AZN) in a $2.4 billion cash deal announced on […]
Moderna, Inc. (NASDAQ: $MRNA): Is the Biotech Giant Still a Buy in 2024 After COVID-19 Vaccine Success?
Moderna, Inc. (NASDAQ: $MRNA) has come a long way since its early days as a relatively unknown biotech company. Founded in 2010, the Cambridge, Massachusetts-based […]
Novavax (NASDAQ: $NVAX) Declines Over 20% After Disappointing Q4 Results
Novavax (NASDAQ: $NVAX) is an American biotech company that focuses on developing vaccines to stop infectious diseases. One of its vaccines, Nuvaxovid, was approved in […]